Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRCA - Verrica Pharmaceuticals Inc.


IEX Last Trade
0.6325
-0.012   -1.818%

Share volume: 0
Last Updated: Fri 27 Dec 2024 03:29:26 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.05%

PREVIOUS CLOSE
CHG
CHG%

$0.64
-0.01
-1.79%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-11 2022-11-07 2023-03-06 2023-05-09 2023-08-08 2023-11-09 2024-02-29 2024-05-13
Total revenue 214.000 K 8.319 M 68.000 K 37.000 K 182.000 K 2.917 M 1.988 M 3.826 M
Cost of revenue 0.000 0.000 725.000 K 68.000 K 136.000 K 270.000 K 272.000 K 1.138 M
Gross profit 214.000 K 8.319 M -657.000 K -31.000 K 46.000 K 2.647 M 1.716 M 2.688 M
    3,787.38% -107.90% 95.28% 248.39% 5,654.35% -35.17% 56.64%  
Operating expenses 9.335 M 6.871 M 5.556 M 7.058 M 11.662 M 26.564 M 22.316 M 21.287 M
Selling general and admin 5.173 M 3.925 M 3.189 M 4.319 M 5.937 M 20.054 M 16.995 M 16.339 M
Research and development 4.162 M 2.946 M 2.367 M 2.739 M 5.725 M 6.510 M 5.321 M 4.948 M
Total expenses 9.335 M 6.871 M 6.281 M 7.126 M 11.798 M 26.834 M 22.588 M 22.425 M
    -26.40% -8.59% 13.45% 65.56% 127.45% -15.82% -0.72%  
Operating income -9.121 M 1.448 M -6.213 M -7.089 M -11.616 M -23.917 M -20.600 M -18.599 M
Ebit -9.121 M 1.448 M -6.213 M -7.089 M -11.616 M -23.917 M -20.600 M -18.599 M
Pretax income -10.168 M 83.000 K -5.932 M -6.589 M -10.990 M -24.802 M -24.614 M -20.331 M
    -100.82% -7,246.99% 11.08% 66.79% 125.68% -0.76% -17.40%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -10.168 M 83.000 K -5.932 M -6.589 M -10.990 M -24.802 M -24.614 M -20.331 M
    100.82% -7,246.99% -11.08% -66.79% -125.68% 0.76% 17.40%  
Net income -10.168 M 83.000 K -5.932 M -6.589 M -10.990 M -24.802 M -24.614 M -20.331 M
    100.82% -7,246.99% -11.08% -66.79% -125.68% 0.76% 17.40%